Disclosed herein are methods of treating subjects suffering from estrogen receptor positive cancer of the brain by administering a selective estrogen receptor degrader (SERM). Also disclosed are methods of treating a cancer that is resistant to an estrogen receptor modulator by administering a SERM.

Disclosed herein are methods of treating subjects suffering from estrogen receptor positive cancer of the brain by administering a selective estrogen receptor degrader (SERM). Also disclosed are methods of treating a cancer that is resistant to an estrogen receptor modulator by administering a SERM.

Disclosed herein are methods of treating subjects suffering from estrogen receptor positive cancer of the brain by administering a selective estrogen receptor degrader (SERM). Also disclosed are methods of treating a cancer that is resistant to an estrogen receptor modulator by administering a SERM.

Disclosed herein are methods of treating subjects suffering from estrogen receptor positive cancer of the brain by administering a selective estrogen receptor degrader (SERM). Also disclosed are methods of treating a cancer that is resistant to an estrogen receptor modulator by administering a SERM.

The present specification relates to a coating composition comprising a compound represented by Chemical Formula 1; and an ionic compound comprising an anion group represented by Chemical Formula 10, an organic light emitting device using the same, and a method for manufacturing the same.

The present specification relates to a coating composition comprising a compound represented by Chemical Formula 1; and an ionic compound comprising an anion group represented by Chemical Formula 10, an organic light emitting device using the same, and a method for manufacturing the same.

Disclosed herein are methods of treating subjects suffering from estrogen receptor positive cancer of the brain by administering a selective estrogen receptor degrader (SERM). Also disclosed are methods of treating a cancer that is resistant to an estrogen receptor modulator by administering a SERM.

Disclosed herein are methods of treating subjects suffering from estrogen receptor positive cancer of the brain by administering a selective estrogen receptor degrader (SERM). Also disclosed are methods of treating a cancer that is resistant to an estrogen receptor modulator by administering a SERM.

The present specification relates to a compound represented by Chemical Formula 1, a coating composition comprising the compound represented by Chemical Formula 1, an organic light emitting device using the same, and a method for manufacturing the same.

The present specification relates to a compound represented by Chemical Formula 1, a coating composition comprising the compound represented by Chemical Formula 1, an organic light emitting device using the same, and a method for manufacturing the same.